A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...

Camcevi ETM, a long-acting injectable, is FDA-approved for advanced prostate cancer, showing 97.9% efficacy in testosterone suppression in a phase 3 study. Common side effects include hot flushing and ...

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society.

Prostate cancer treatment could be "supercharged" by a new way of weakening malignant cells, say scientists. A new ...

Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...

Researchers at Queen’s University Belfast have developed a new radiosensitiser with the ability to render prostate cancer cells up to 30% more sensitive to radiotherapy. Previous research has ...

Scripps Health in recent years has been using what are described as “medical smart bombs” to help treat patients who have advanced prostate cancer. And with the introduction of new technology in ...

An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid ...

New ‘gentler’ treatment for prostate cancer gets green light but not all men will have access to it - It comes as concerns ...